Question Everything. See who's reporting it.

Aurobindo subsidiary launches ADQUEY ointment in US

Source: Telangana Today

The story in brief

Acrotech Biopharma, a subsidiary of Aurobindo Pharma, launched ADQUEY ointment in the US for mild-to-moderate atopic dermatitis. The product, originally developed by Otsuka Pharmaceutical, is now available for adults and children aged 2 and older. Acrotech aims to build a dermatology platform to support ADQUEY and future opportunities. The launch marks Acrotech's entry into the American dermatology market.

NEWXFree on Android and iPhone. Open in NEWX